Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca Ruchika Sharma29 Oct 2025 10:30 AM ISTAlexion, AstraZeneca Rare Disease's Koselugo (selumetinib), an oral, selective MEK inhibitor, has been approved in the European Union (EU) for...
FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps Dr. Kamal Kant Kohli24 Oct 2025 8:15 PM ISTThe FDA has approved Tezspire (tezepelumab-ekko), a biologic therapy by Amgen and AstraZeneca, as an add-on maintenance treatment for patients aged 12...
AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps Ruchika Sharma23 Oct 2025 11:45 AM ISTAstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the European Union (EU) as an add-on therapy with intranasal corticosteroids...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus Ruchika Sharma20 Oct 2025 1:00 PM ISTAstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a self-administered...
AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps Ruchika Sharma18 Oct 2025 11:30 AM ISTAstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged...
Baxdrostat Shows Significant Blood Pressure Reduction in Resistant Hypertension in Phase III trial Dr. Kamal Kant Kohli16 Oct 2025 7:45 AM ISTBaxdrostat, a novel aldosterone synthase inhibitor, demonstrated a highly clinically meaningful reduction in 24-hour ambulatory systolic blood...
AstraZeneca Gets SEC Nod for New Trastuzumab Deruxtecan Indication in HER2-Positive Solid Tumors Parthika Patel10 Oct 2025 8:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended approval for an additional...
AstraZeneca to harmonise its listing structure across LSE, STO and NYSE Ruchika Sharma30 Sept 2025 12:00 PM ISTCambridge: AstraZeneca plans to harmonise its share listing structure to deliver a global listing for global investors in a global company. The...
AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1 Ruchika Sharma28 Sept 2025 4:45 PM ISTAstraZeneca has announced that Koselugo (selumetinib), an oral, selective MEK inhibitor, has been recommended for approval in the European...
Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology Ruchika Sharma27 Sept 2025 5:30 PM ISTBiotech firm Factor Bioscience has filed a lawsuit against Cellectis and AstraZeneca, accusing the companies of allegedly infringing three patents...
AstraZeneca-Daiichi Sankyo get USFDA grants priority review for Enhertu combo for 1st line HER2+ Breast cancer treatment Ruchika Sharma24 Sept 2025 12:46 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) in combination...
AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps Ruchika Sharma22 Sept 2025 2:00 PM ISTCambridge: AstraZeneca and Amgen's Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult...
